Articles

Elsevier, The Lancet Planetary Health, Volume 5, July 2021
Background: Europe has emerged as a major climate change hotspot, both in terms of an increase in seasonal averages and climate extremes. Projections of temperature-attributable mortality, however, have not been comprehensively reported for an extensive part of the continent. Therefore, we aim to estimate the future effect of climate change on temperature-attributable mortality across Europe. Methods: We did a time series analysis study.
Elsevier, One Earth, Volume 4, 23 July 2021
To limit global warming to well-below 2°C (WB2C), fossil fuels must be replaced by low-carbon energy sources. Support for this transition is often dampened by the impact on fossil fuel jobs. Previous work shows that pro-climate polices could increase employment by 20 million net energy jobs, but these studies rely on Organisation for Economic Co-operation and Development (OECD) jobs data, assumptions about jobs in non-OECD countries, and a single baseline assumption.
Elsevier, iScience, Volume 24, 23 July 2021
Owing to its versatility, biomass can be used for a range of CO2 mitigation and removal options. The recent adoption of end-of-century temperature targets at the global scale, along with mid-century economy-wide net zero emission targets in Europe, has boosted demand forecasts for this valuable resource. Given the limited nature of sustainable biomass supply, it is important to understand most efficient uses of biomass, both in terms of avoided CO2 emissions (i.e., substituted energy and economic services) and CO2 removal.
Elsevier,

iScience, Volume 24, 23 July 2021

Economically viable electric vehicle lithium-ion battery recycling is increasingly needed; however routes to profitability are still unclear. We present a comprehensive, holistic techno-economic model as a framework to directly compare recycling locations and processes, providing a key tool for recycling cost optimization in an international battery recycling economy. We show that recycling can be economically viable, with cost/profit ranging from (−21.43 - +21.91) $·kWh−1 but strongly depends on transport distances, wages, pack design and recycling method.

Elsevier,

The Lancet Planetary Health, Volume 5, July 2021

Record climate extremes are reducing urban liveability, compounding inequality, and threatening infrastructure. Adaptation measures that integrate technological, nature-based, and social solutions can provide multiple co-benefits to address complex socioecological issues in cities while increasing resilience to potential impacts. However, there remain many challenges to developing and implementing integrated solutions.

Elsevier,

CJC Open, Volume 3, December 2021

The authors evaluated the quality and outcomes of in-hospital ACS management for White patients vs patients of colour, within a universal healthcare context.
Elsevier,

The Lancet Public Health, Volume 6, July 2021

This Viewpoint supports SDG 3 by exploring the reasons behind inadequate PrEP uptake to date and offering considerations for effective scale up to meet 2030 UNAIDS targets.
Elsevier,

Blood Advances, Volume 5, 27 July 2021

We conducted a retrospective multicenter international analysis to identify prognostic factors, survival, and treatment-related outcomes in patients with HIV-BL contemporaneously treated. In this large collaborative effort, we analyzed a cohort of 249 patients with newly diagnosed HIV-BL treated at 35 centers in the United States and United Kingdom.
Elsevier, Pulmonology, Volume 27, 1 July 2021
Objective: Smoking is an important causative factor of chronic obstructive pulmonary disease (COPD), and females are considered more susceptible to the effects of smoking than males. However, in previous Korean studies, the effects of sex differences on the association between smoking and COPD have been controversial. In this study, the effects of sex differences on the association between smoking and COPD and the effects of female hidden smokers on that association in Korean adults were investigated.
Elsevier, Neurochemistry International, Volume 147, July 2021
Alzheimer's disease (AD) is by far the most prevalent neurodegenerative disease of aging and is a major burden for patients, caregivers, and the overall health care system. The complexity of AD pathophysiology and the lack of deep understanding of disease mechanisms impeded the development of AD therapy. Currently approved treatments for AD only modestly improve cognitive function but do not modify disease course. The lack of pharmacological approaches has led to the consideration of alternative strategies to prevent or to slow down the progression of AD.

Pages